tirzepatide in tablet form ORAL TABLETS Tirzepatide Oral Rapid Dissolve Sublingual

What the research firmly supports: BPC-157's gut healing, vascular, and neuroprotective mechanisms (strong preclinical evidence) Thymosin Alpha-1's immune modulating and T-cell restorative effects (strong preclinical + clinical evidence in viral disease) TB-500's cardiovascular repair and angiogenic properties (strong preclinical, early human data) What the research does not yet confirm: Randomised controlled trial data specifically in long COVID populations Optimal dosing, sequencing, and duration specifically for PASC Long-term safety data for extended post-viral use This doesn't mean these peptides don't work for long COVID

Delivery System Research Researchers continue evaluating intranasal formulations to investigate peptide transport, pharmaceutical technologies, formulation optimisation, and experimental bioavailability

Here are a few factors to consider: Weight and Body Composition: Patients with higher body weights may require slightly higher doses to achieve the same effects

Learn more about the Health Library and our editorial process